∆9-tetrahydrocannabinol (THC) inhibits melanoma tumor growth, according to a study published in the most recent issue of the journal Life Science, and published online by the National Institute of Health. For the study, researchers “examined the effect of THC, which binds to CB receptors (CB1, CB2), on the growth of the mouse melanoma… in vitro …
Cannabinoids have strong antitumor capabilities according to a new study being published in the upcoming issue of the journal Histology and Histopathology, and e-published ahead of print by the National Institute of Health. “Cannabinoids are a class of chemical compounds with a wide spectrum of pharmacological effects, mediated by two specific plasma membrane receptors (CB1 …
A new study published by the National Institute of Health has found that cannabidiol – a cannabis compound – attacks tumor cells, inhibiting them from further growth, by affecting “multiple tumoral features and molecular pathways”. “In the present study, we found that CBD inhibited U87-MG and T98G cell proliferation and invasiveness in vitro and caused …
A Harvard study from 2007 which remains the most comprehensive ever released on THC’s potential to combat tumors found that in just three weeks doses of THC were able to cut lung cancer tumor growth in half in mice subjects, and were able to reduce cancer lesions by even more. For the study, Harvard researchers …
